Fetal Dose from PET and CT in Pregnant Patients
Journal of Nuclear Medicine · 2023-02 · 64 (2) · 312-319
DOI: 10.2967/jnumed.122.263959 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Nuclear Medicine, online erschienen am 08.09.2022. Verfasst von Christiane Sarah Burton und 6 weiteren Autor:innen. Beteiligte Einrichtung: St. Jude Children's Research Hospital, Memphis, Tennessee; christiane.burton@stjude.org. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Fluorodeoxyglucose F18. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 49 Literaturangaben.
Abstract (Originalsprache)
When pregnancy is discovered during or after a diagnostic examination, the physician or the patient may request an estimate of the radiation dose received by the fetus as per guidelines and standard operating procedures. This study provided the imaging community with dose estimates to the fetus from PET/CT with protocols that are adapted to University of Michigan low-dose protocols for patients known to be pregnant.
Methods
There were 9 patients analyzed with data for the first, second, and third trimesters, the availability of which is quite rare. These images were used to calculate the size-specific dose estimate (SSDE) from the CT scan portion and the SUV and 18F-FDG uptake dose from the PET scan portion using the MIRD formulation. The fetal dose estimates were tested for correlation with each of the following independent measures: gestational age, fetal volume, average water-equivalent diameter of the patient along the length of the fetus, SSDE, SUV, and percentage of dose from 18F-FDG. Stepwise multiple linear regression analysis was performed to assess the partial correlation of each variable. To our knowledge, this was the first study to determine fetal doses from CT and PET images.
Results
Fetal self-doses from 18F for the first, second, and third trimesters were 2.18 mGy (single data point), 0.74-1.82 mGy, and 0.017-0.0017 mGy, respectively. The combined SSDE and fetal self-dose ranged from 1.2 to 8.2 mGy. These types of images from pregnant patients are rare.
Conclusion
Our data indicate that the fetal radiation exposure from 18F-FDG PET and CT performed, when medically necessary, on pregnant women with cancer is low. All efforts should be made to minimize fetal radiation exposure by modifying the protocol.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- St. Jude Children's Research Hospital, Memphis, Tennessee; christiane.burton@stjude.org.
- Michigan Medicine, Ann Arbor, Michigan.
- Children's Hospital, Boston, Massachusetts.
- University of Michigan, Ann Arbor, Michigan; and.
- University of Utah School of Medicine, Salt Lake City, Utah.
- St. Jude Children's Research Hospital, Memphis, Tennessee.
Zitieren
APA
Burton, C. S., Frey, K., Fahey, F., Kaminski, M. S., Brown, R. K. J., Pohlen, J. M., & Shulkin, B. L. (2023). Fetal Dose from PET and CT in Pregnant Patients. Journal of Nuclear Medicine, 64(2), 312-319. https://doi.org/10.2967/jnumed.122.263959
Vancouver
Burton CS, Frey K, Fahey F, Kaminski MS, Brown RKJ, Pohlen JM, et al. Fetal Dose from PET and CT in Pregnant Patients. Journal of Nuclear Medicine. 2023;64(2):312-319. doi:10.2967/jnumed.122.263959
BibTeX
@article{Burton2023,
author = {Burton, Christiane Sarah and Frey, Kirk and Fahey, Frederic and Kaminski, Mark S and Brown, Richard K J and Pohlen, Judith M and Shulkin, Barry L},
title = {Fetal Dose from PET and CT in Pregnant Patients},
journal = {Journal of Nuclear Medicine},
year = {2023},
volume = {64},
number = {2},
pages = {312--319},
doi = {10.2967/jnumed.122.263959}
}
EUVIMED